On August 15, 2017, BioAmber Inc. (NYSE:BIOA) closed the transaction. The company issued 299,998 shares for gross proceeds of $224,998. The transaction involved participation from Director Kurt W. Briner for 133,333 shares, Director Heinz Haller for 40,000 shares, Chief Technology Officer Millis James for 13,333 shares, Director Ellen B. Richstone for 13,333 shares, Chief Financial Officer Settino Mario for 20,000 shares, Director Raymond J. Land for 40,000 shares, Executive Vice President Michael Hartmann for 13,333 shares, and Chief Operations Officer Orecchioni Fabrice for 26,666 shares.